In vitro models for human skin disease

Drug Discovery Today

Volumn 16, Issue 3-4, 2011, Pages 132-139

  Semlin, Lydia ^a   Schäfer Korting, Monika ^b   Borelli, Claudia ^a   Korting, Hans C ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; CHEMOKINE RECEPTOR CXCR2; COSMETIC; ECONAZOLE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 8; PROTEINASE INHIBITOR; SAQUINAVIR; TERBINAFINE; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ATOPIC DERMATITIS; AUTOIMMUNE SKIN DISEASE; BACTERIAL COLONIZATION; DERMATOMYCOSIS; DERMATOPHYTOSIS; DRUG EFFICACY; DRUG RESEARCH; HUMAN; IN VITRO STUDY; MELANOMA; NONHUMAN; PHOTODERMATOSIS; PRODUCT SAFETY; PSORIASIS VULGARIS; REVIEW; SKIN ALLERGY; SKIN CANCER; SKIN DISEASE; THRUSH; TOXICITY TESTING; VAGINA CANDIDIASIS; WOUND HEALING; WOUND INFECTION; XERODERMA PIGMENTOSUM;

ANIMAL TESTING ALTERNATIVES; ANIMALS; DRUG DISCOVERY; EPITHELIUM; HUMANS; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS; SKIN; SKIN DISEASES; TISSUE CULTURE TECHNIQUES;

EID: 79851515406     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drudis.2010.12.001     Document Type: Review

References (71)

1. L.H. Kligman, and A.M. Kligman The effect on rhino mouse skin of agents which influence keratinization and exfoliation J. Invest. Dermatol. 73 1979 354 358 (Pubitemid 10165037)
2. J.A. Mezick Topical and systemic effects of retinoids on horn-filled utriculus size in the rhino mouse. A model to quantify " antikeratinizing" effects of retinoids J. Invest. Dermatol. 83 1984 110 113
3. E. Hsia Effects of topically applied acitretin in reconstructed human epidermis and the rhino mouse J. Invest. Dermatol. 128 2008 125 130 (Pubitemid 350249384)
4. M. Ponec In vitro cultured human skin cells as alternatives to animals for skin irritancy screening Int. J. Cosmet. Sci. 14 1992 245 264
5. H.P. Ehrlich Understanding experimental biology of skin equivalent: from laboratory to clinical use in patients with burns and chronic wounds Am. J. Surg. 187 2004 29S 33S (Pubitemid 38625985)
6. F. Braye Skin substitutes reconstructed in the laboratory: application in burn treatment Pathol. Biol. (Paris) 53 2005 613 617
7. OECD (2004) Test Guideline 431: In vitro skin corrosion: human skin model test. Adopted on 13th April 2004
8. M.K. Robinson Non-animal testing strategies for assessment of the skin corrosion and skin irritation potential of ingredients and finished products Food Chem. Toxicol. 40 2002 573 592 (Pubitemid 34310423)
9. H. Spielmann, and M. Liebsch Lessons learned from validation of in vitro toxicity test: from failure to acceptance into regulatory practice Toxicol. In Vitro 15 2001 585 590 (Pubitemid 32889689)
10. OECD (2004) Test Guideline 432: In vitro 3T3 NRU phototoxicity test. Adopted on 13th April 2004
11. OECD (2008) Guideline for the testing of chemicals, draft proposal for a new guideline: in vitro skin irritation: human skin model test. Paris, France, 2008
12. F. Netzlaff The human epidermis models EpiSkin (R), SkinEthic (R) and EpiDerm (R): an evaluation of morphology and their suitability for testing phototoxicity, irritancy, corrosivity, and substance transport Eur. J. Pharm. Biopharm. 60 2005 167 178 (Pubitemid 40804559)
13. M. Schäfer-Korting The use of reconstructed human epidermis for skin absorption testing: results of the validation study Altern. Lab. Anim. 36 2008 161 187 (Pubitemid 351861001)
14. A. Gysler Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin Pharm. Res. 16 1999 1386 1391 (Pubitemid 29449375)
15. S. Lombardi Borgia In vitro skin absorption and drug release - a comparison of six commercial prednicarbate preparations for topical use Eur. J. Pharm. Biopharm. 68 2008 380 389
16. C. Santos Maia Drug targeting by solid lipid nanoparticles for dermal use J. Drug Target. 10 2002 489 495
17. S. Küchler Nanoparticles for skin penetration enhancement - a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles Eur. J. Pharm. Biopharm. 71 2009 243 250
18. N.B. Wolf Influences of opioids and nanoparticles on in vitro wound healing models Eur. J. Pharm. Biopharm. 73 2009 34 42
19. H.C. Korting A model of human cutaneous candidosis based on reconstructed human epidermis for the light and electron microscopic study of pathogenesis and treatment J. Infect. 36 1998 259 267 (Pubitemid 28291473)
20. M. Schaller Differential expression of secreted aspartyl proteinases in a model of human oral candidosis and in patient samples from the oral cavity Mol. Microbiol. 29 1998 605 615 (Pubitemid 28330792)
21. M. Schaller Light and electron microscopic findings in a model of human cutaneous candidosis based on reconstructed human epidermis following the topical application of different econazole formulations J. Drug Target. 6 1999 361 372 (Pubitemid 29237592)
22. H.C. Korting the Ecosom Collaborative Study Group Comparative efficacy and tolerability of econazole liposomal gel 1%, branded econazole conventional cream 1% and generic clotrimazole cream 1% in Tinea pedis Clin. Drug Investig. 14 2007 286 293
23. A. Bonowitz Comparative therapeutic and toxic effects of different povidone iodine (PVP-I) formulations in a model of oral candidosis based on in vitro reconstituted epithelium J. Drug Target. 9 2001 75 83 (Pubitemid 32496452)
24. A. Rougier In vitro skin toxicology irritation, phototoxicity, sensitization 1994 Liebert New York, NY
25. K. Kemp Disease models - one size does not fit all Drug Discov. Today 15 2010 161 162
26. M. Schaller Secreted aspartic proteinase (Sap) activity contributes to tissue damage in a model of human oral candidosis Mol. Microbiol. 34 1999 169 180 (Pubitemid 29460495)
27. H.C. Korting Reduced expression of the hyphal-independent Candida albicans proteinase genes SAP1 and SAP3 in the efg1 mutant is associated with attenuated virulence during infection of oral epithelium J. Med. Microbiol. 52 2003 623 632 (Pubitemid 36981468)
28. M. Schaller Infection of human oral epithelia with Candida species induces cytokine expression correlated to the degree of virulence J. Invest. Dermatol. 118 2002 652 657 (Pubitemid 34309985)
29. M. Schaller Toxicity and antimicrobial activity of a hydrocolloid dressing containing silver particles in an ex vivo model of cutaneous infection Skin Pharmacol. Physiol. 17 2004 31 36 (Pubitemid 38250477)
30. G. Weindl Human epithelial cells establish direct antifungal defense through TLR4-mediated signaling J. Clin. Invest. 117 2007 3664 3672 (Pubitemid 350224078)
31. L. Hoegl HIV protease inhibitors influence the prevalence of oral candidosis in HIV-infected patients: a 2-year study Mycoses 41 1998 321 325 (Pubitemid 28553053)
32. H.C. Korting Effects of the human immunodeficiency virus (HIV) proteinase inhibitors saquinavir and indinavir on in vitro activities of secreted aspartyl proteinases of Candida albicans isolates from HIV-infected patients Antimicrob. Agents Chemother. 43 1999 2038 2042 (Pubitemid 29395205)
33. M. Schaller The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal candidiasis based on reconstituted human vaginal epithelium Infect. Immun. 71 2003 3227 3234 (Pubitemid 36637547)
34. C. Scherwitz Ultrastructure of human cutaneous candidosis J. Invest. Dermatol. 78 1982 200 205 (Pubitemid 12171879)
35. M. Schaller Cytokine expression induced by Candida albicans in a model of cutaneous candidosis based on reconstituted human epidermis J. Med. Microbiol. 51 2002 672 676 (Pubitemid 34804291)
36. A. Rashid Activity of terbinafine on Trichophyton mentagrophytes in a human living skin equivalent model J. Med. Vet. Mycol. 33 1995 229 233
37. T.G. Smijs A novel ex vivo skin model to study the susceptibility of the dermatophyte Trichophyton rubrum to photodynamic treatment in different growth phases J. Antimicrob. Chemother. 59 2007 433 440 (Pubitemid 47073448)
38. D.B. Holland Microbial colonization of an in vitro model of a tissue engineered human skin equivalent - a novel approach FEMS Microbiol. Lett. 279 2008 110 115 (Pubitemid 350308557)
39. D.B. Holland Differential innate immune responses of a living skin equivalent model colonized by Staphylococcus epidermidis or Staphylococcus aureus FEMS Microbiol. Lett. 290 2009 149 155
40. R. O'Leary Characterization of the living skin equivalent as a model of cutaneous re-epithelialization Cell Biochem. Funct. 20 2002 129 141
41. M.B. Vaughan A reproducible laser-wounded skin equivalent model to study the effects of aging in vitro Rejuvenation Res. 7 2004 99 110 (Pubitemid 39150061)
42. A.T. Yeh Imaging wound healing using optical coherence tomography and multiphoton microscopy in an in vitro skin-equivalent tissue model J. Biomed. Opt. 9 2004 248 253
43. S. Küchler 3D-wound healing model: influence of morphine and solid lipid nanoparticles J. Biotechnol. 148 2010 24 30
44. H.C. Korting, and M. Schäfer-Korting Carriers in the topical treatment of skin disease M. Schäfer-Korting, Handbook of Experimental Pharmacology, vol. 197: Drug Delivery 2009 Springer Heidelberg
45. M. Schäfer-Korting Lipid nanoparticles for improved topical application of drugs for skin diseases Adv. Drug Deliv. Rev. 59 2007 427 443 (Pubitemid 47259224)
46. C. Stein Peripheral mechanisms of pain and analgesia Brain Res. Rev. 60 2009 90 113
47. M. Cario-Andre The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis Pigment Cell Res. 20 2007 385 393 (Pubitemid 47390111)
48. J. Jean Development of an in vitro psoriatic skin model by tissue engineering J. Dermatol. Sci. 53 2009 19 25
49. G. Tjabringa Development and validation of human psoriatic skin equivalents Am. J. Pathol. 173 2008 815 823
50. C.L. Barker The development and characterization of an in vitro model of psoriasis J. Invest. Dermatol. 123 2004 892 901 (Pubitemid 39391935)
51. V. Mils Comparative analysis of normal and psoriatic skin both in vivo and in vitro Differentiation 58 1994 77 86 (Pubitemid 24361129)
52. T. Cheng The cystatin M/E-controlled pathway of skin barrier formation: expression of its key components in psoriasis and atopic dermatitis Br. J. Dermatol. 161 2009 253 264
53. K. Engelhart In vitro reproduction of clinical hallmarks of eczematous dermatitis in organotypic skin models Arch. Dermatol. Res. 297 2005 1 9 (Pubitemid 41380676)
54. V. Oji Loss of corneodesmosin leads to severe skin barrier defect, pruritus and atopy: unravelling the peeling skin disease Am. J. Hum. Genet. 87 2010 274 281
55. E. Proksch Role of the epidermal barrier in atopic dermatitis J. Dtsch. Dermatol. Ges. 7 2009 899 910
56. de Brugerolle de Fraissinette Predictivity of an in vitro model for acute and chronic skin irritation (SkinEthic) applied to the testing of topical vehicles Cell Biol. Toxicol. 15 1999 121 135 (Pubitemid 29277507)
57. V. Facy Langerhans cells integrated into human reconstructed epidermis respond to known sensitizers and ultraviolet exposure J. Invest. Dermatol. 122 2004 552 553 (Pubitemid 38281083)
58. F. Bernerd Human skin reconstructed in vitro as a model to study keratinocyte, the fibroblast and their interactions: photodamage and repair processed J. Soc. Biol. 199 2005 313 320 (Pubitemid 43825042)
59. F. Bernerd, and D. Asselineau An organotypic model of skin to study photodamage and photoprotection in vitro J. Am. Acad. Dermatol. 58 Suppl. 2 2008 155 159
60. F. Bernerd Evaluation of the protective effect of sunscreens on in vitro reconstructed human skin exposed to UVB or UVA irradiation Photochem. Photobiol. 71 2000 314 320
61. C. Duval The use of reconstructed human skin to evaluate UV-induced modifications and sunscreen efficacy Exp. Dermatol. 12 Suppl. 2 2003 64 70 (Pubitemid 37526851)
62. T. Hakozaki Visualization and characterization of UVB-induced reactive oxygen species in a human skin equivalent model Arch. Dermatol. Res. 300 Suppl. 1 2008 S51 S56
63. N. Bechetoille Effects of solar ultraviolet radiation on engineered human skin equivalent containing both Langerhans cells and dermal dendritic cells Tissue Eng. 13 2007 2667 2679 (Pubitemid 350076746)
64. A. Schwarz Green tea phenol extracts reduce UVB-induced DNA damage in human cells via interleukin-12 Photochem. Photobiol. 84 2008 350 355 (Pubitemid 351424031)
65. H. Pageon Reconstructed skin modified by glycation of the dermal equivalent as a model for skin aging and its potential use to evaluate anti-glycation molecules Exp. Gerontol. 43 2008 584 588
66. F. Bernerd Clues to epidermal cancer proneness revealed by reconstruction of DNA repair-deficient xeroderma pigmentosum skin in vitro Proc. Natl. Acad. Sci. U.S.A. 98 2001 7817 7822 (Pubitemid 32642644)
67. A.H. Borchers Fibroblast-directed expression and localization of 92-kDa type IV collagenase along the tumor-stroma interface in an in vitro three-dimensional model of human squamous cell carcinoma Mol. Carcinog. 19 1997 258 266 (Pubitemid 27392005)
68. C. Bouez The lysyl oxidase LOX is absent in basal and squamous cell carcinomas and its knockdown induces an invading phenotype in a skin equivalent model Clin. Cancer Res. 12 2006 1463 1469
69. S. Commandeur An in vitro three-dimensional model of primary human cutaneous squamous cell carcinoma Exp. Dermatol. 18 2009 849 856
70. D.H. Obrigkeit Effects of photodynamic therapy evaluated in a novel three-dimensional squamous cell carcinoma organ construct of the skin Photochem. Photobiol. 85 2009 272 278
71. P. Eves Characterization of an in vitro model of human melanoma invasion based on reconstructed human skin Br. J. Dermatol. 142 2000 210 222 (Pubitemid 30117688)